Lianyungang, China

Xin Huang


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xin Huang - Innovator in Pharmaceutical Composition

Introduction

Xin Huang is an esteemed inventor based in Lianyungang, China. With a keen focus on pharmaceutical innovations, he has made significant contributions to the field, particularly in the area of drug formulation. His commitment to enhancing pharmaceutical efficacy is evident through his groundbreaking work.

Latest Patents

Xin Huang holds one notable patent titled "Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof." This patent outlines a unique pharmaceutical composition that involves a layered approach, integrating vitamin C and dabigatran etexilate, separated by a semipermeable film layer. The composition's innovative structure includes both water-soluble and water-insoluble compounds, contributing to its advanced formulation and effectiveness.

Career Highlights

He is currently employed at Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to drive research and development initiatives that focus on creating robust pharmaceutical products. His expertise in the area of drug formulation has positioned him as a pivotal team member in the advancement of medical therapies.

Collaborations

Throughout his career, Xin Huang has collaborated with notable colleagues including Xiongxiong He and Ping Dong. Their contributions have greatly enhanced the scope and impact of their collective research efforts, fostering an environment of innovation and collaboration in their projects.

Conclusion

In summary, Xin Huang's patent and ongoing work at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. exemplify his dedication to pharmaceutical advancements. His innovative approaches contribute significantly to the field, showcasing the importance of creativity and technical expertise in developing effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…